Free data on 57M+ companies

Home > England & Wales Companies > TRANSLATION PHARMA LIMITED

Company Information for

TRANSLATION PHARMA LIMITED

CAMBURGH HOUSE, 27, NEW DOVER ROAD, CANTERBURY, KENT, CT1 3DN,

Company Registration Number

09316639

Private Limited Company

Active

Company Overview

About Translation Pharma Ltd

TRANSLATION PHARMA LIMITED was founded on 2014-11-18 and has its registered office in Canterbury. The organisation's status is listed as "Active". Translation Pharma Limited is a Private Limited Company registered in UNITED KINGDOM with Companies House and the accounts submission requirement is categorised as TOTAL EXEMPTION FULL

Company qualifies as a small company
Company has filed full accounts
Company is exempt from audit
Annual turnover is less than £6.5 million
The balance sheet total is less than £ 3.26 million
Employs less than 50 employees

Key Data

Legal Registered Office
Company Name
TRANSLATION PHARMA LIMITED

CAMBURGH HOUSE, 27 NEW DOVER ROAD CANTERBURY KENT CT1 3DN

Filing Information

Company Number		09316639
Company ID Number		09316639
Date formed		2014-11-18
Country		UNITED KINGDOM
Origin Country		United Kingdom
Type		Private Limited Company
CompanyStatus		Active
Lastest accounts		31/01/2024
Account next due		31/10/2025
Latest return		18/11/2015
Return next due		16/12/2016
Type of accounts		TOTAL EXEMPTION FULL
VAT Number /Sales tax ID		GB203758124

Last Datalog update:	2024-07-05 16:57:22
Primary Source:	Companies House

Is this data useful to you?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of TRANSLATION PHARMA LIMITED

Current Directors

Officer	Role	Date Appointed
ALEXANDER ROBERT LEECH	Director	2014-11-18
KATHERINE JANE LEECH	Director	2015-09-10
ALASDAIR MARK NAYLOR	Director	2014-11-18
LOUISE HELEN NAYLOR	Director	2015-09-10

Related Directorships

Officer	Related Company	Role	Date Appointed	Role Status	Incorporation date	Company Status
ALEXANDER ROBERT LEECH	ZARODEX THERAPEUTICS LIMITED	Director	2018-02-28	CURRENT	2017-07-26	Liquidation
ALEXANDER ROBERT LEECH	CAMPHOS THERAPEUTICS LIMITED	Director	2017-10-21	CURRENT	2017-03-01	Active
ALEXANDER ROBERT LEECH	TCCG LIMITED	Director	2010-03-16	CURRENT	2010-03-16	Dissolved 2016-03-10
KATHERINE JANE LEECH	TCCG LIMITED	Director	2013-04-01	CURRENT	2010-03-16	Dissolved 2016-03-10
ALASDAIR MARK NAYLOR	TCCG LIMITED	Director	2010-03-16	CURRENT	2010-03-16	Dissolved 2016-03-10
LOUISE HELEN NAYLOR	TCCG LIMITED	Director	2013-04-01	CURRENT	2010-03-16	Dissolved 2016-03-10
LOUISE HELEN NAYLOR	ST. EDMUND'S SCHOOL CANTERBURY	Director	2009-12-16	CURRENT	1996-05-20	Active

More director information

Corporation Filing History

Companies House Filing History

This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

Date	Document Type	Document Description
2024-07-03		Resolutions passed:<ul><li>Special resolution for voluntary liquidation to wind up with case start date</ul>
2024-07-03		Appointment of a voluntary liquidator
2024-07-03		Voluntary liquidation declaration of solvency
2024-07-03		REGISTERED OFFICE CHANGED ON 03/07/24 FROM Camburgh House, 27 New Dover Road Canterbury Kent CT1 3DN United Kingdom
2024-05-03		31/01/24 ACCOUNTS TOTAL EXEMPTION FULL
2024-04-24		Previous accounting period extended from 30/11/23 TO 31/01/24
2023-11-28		CONFIRMATION STATEMENT MADE ON 18/11/23, WITH NO UPDATES
2023-07-27		30/11/22 ACCOUNTS TOTAL EXEMPTION FULL
2022-08-30		30/11/21 ACCOUNTS TOTAL EXEMPTION FULL
2022-08-30	AA	30/11/21 ACCOUNTS TOTAL EXEMPTION FULL
2021-11-23	CS01	CONFIRMATION STATEMENT MADE ON 18/11/21, WITH NO UPDATES
2021-08-24	AA	30/11/20 ACCOUNTS TOTAL EXEMPTION FULL
2020-11-18	CS01	CONFIRMATION STATEMENT MADE ON 18/11/20, WITH NO UPDATES
2020-09-09	AA	30/11/19 ACCOUNTS TOTAL EXEMPTION FULL
2019-12-03	CS01	CONFIRMATION STATEMENT MADE ON 18/11/19, WITH NO UPDATES
2019-08-20	AA	30/11/18 ACCOUNTS TOTAL EXEMPTION FULL
2019-01-23	CS01	CONFIRMATION STATEMENT MADE ON 18/11/18, WITH UPDATES
2018-08-17	AA	30/11/17 ACCOUNTS TOTAL EXEMPTION FULL
2017-12-21	LATEST SOC	21/12/17 STATEMENT OF CAPITAL;GBP 100
2017-12-21	CS01	CONFIRMATION STATEMENT MADE ON 18/11/17, WITH UPDATES
2017-12-21	CS01	CONFIRMATION STATEMENT MADE ON 18/11/17, WITH UPDATES
2017-08-30	AA	30/11/16 ACCOUNTS TOTAL EXEMPTION SMALL
2017-01-17	LATEST SOC	17/01/17 STATEMENT OF CAPITAL;GBP 100
2017-01-17	CS01	CONFIRMATION STATEMENT MADE ON 18/11/16, WITH UPDATES
2016-08-17	AA	30/11/15 ACCOUNTS TOTAL EXEMPTION SMALL
2016-02-26	RES13	SHARES RANK PARI PASSU AS REGARDS INCOME 10/09/2015
2016-02-26	RES12	Resolution of varying share rights or name
2016-02-26	SH08	Change of share class name or designation
2016-02-17	DISS40	Compulsory strike-off action has been discontinued
2016-02-16	AR01	18/11/15 ANNUAL RETURN FULL LIST
2016-02-16	AP01	DIRECTOR APPOINTED MRS LOUISE HELEN NAYLOR
2016-02-16	AP01	DIRECTOR APPOINTED MRS KATHERINE JANE LEECH
2016-02-16	GAZ1	FIRST GAZETTE notice for compulsory strike-off
2014-11-18	LATEST SOC	18/11/14 STATEMENT OF CAPITAL;GBP 100
2014-11-18	NEWINC	New incorporation

Industry Information

SIC/NAIC Codes

72 - Scientific research and development

721 - Research and experimental development on natural sciences and engineering

72110 - Research and experimental development on biotechnology

Licences & Regulatory approval

We could not find any licences issued to TRANSLATION PHARMA LIMITED or authorisation from an industry specific regulator to operate. These may not be required.

Share this page on Facebook

Risks

Legal Notices

Notices to Creditors	2024-07-03
Appointment of Liquidators	2024-07-03
Resolutions for Winding-up	2024-07-03

Fines / Sanctions

No fines or sanctions have been issued against TRANSLATION PHARMA LIMITED

Liabilities

Mortgages / Charges

Total # Mortgages/Charges	0
Mortgages/Charges outstanding	0
Mortgages Partially Satisifed	0
Mortgages Satisfied/Paid	0

Details of Mortgagee Charges

TRANSLATION PHARMA LIMITED does not have any mortgage charges so there is no mortgagee data available

Average

Max

This shows the max and average number of mortgages for companies with the same SIC code of 72110 - Research and experimental development on biotechnology

Filed Financial Reports

Annual Accounts
2016-11-30

Annual Accounts
2017-11-30

Annual Accounts
2018-11-30

Annual Accounts
2019-11-30

Annual Accounts
2020-11-30

Annual Accounts
2021-11-30

These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on TRANSLATION PHARMA LIMITED

Intangible Assets

Patents

We have not found any records of TRANSLATION PHARMA LIMITED registering or being granted any patents

Domain Names

We do not have the domain name information for TRANSLATION PHARMA LIMITED

Trademarks

We have not found any records of TRANSLATION PHARMA LIMITED registering or being granted any trademarks

Income

Government Income

We have not found government income sources for TRANSLATION PHARMA LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as TRANSLATION PHARMA LIMITED are:

Outgoings

Business Rates/Property Tax

No properties were found where TRANSLATION PHARMA LIMITED is liable for the business rates / property tax. This could be for a number of reasons.

The council hasnt published the data
We havent found or been able to process the councils data
The company is part of a group of companies and another company in the group is liable for business rates
The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.

Government Grants / Awards

Technology Strategy Board Awards

The Technology Strategy Board has not awarded TRANSLATION PHARMA LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR

European Union CORDIS Awards

The European Union has not awarded TRANSLATION PHARMA LIMITED any grants or awards.

Ownership

We could not find any group structure information

Is this data useful to you?

Need more information?

We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.